Neobe Therapeutics
Neobe Therapeutics is building a synthetic biology platform of programmable microbial trojan horses that remodel the microenvironment of solid tumours, enabling immunotherapy in immune excluded patients.
$6.8M Seed ·
Led by Arc Ventures · Source: european-biotechnology.com
Total raised: $9.14M across 2 sourced rounds
All 2 rounds ↓Signals
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $6.8M | european-biotechnology.com | ||
| Round | $2.34M | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
PC
Pedro Correa de Sampaio Co-founder and CEOsource: neobetherapeutics.comAS
Annelise Soulier Co-founder and CSOsource: neobetherapeutics.com
Investors
22048 Ventures
AArc Ventureslead investor
DDeep Science Ventures
DDiscovery Park Ventures
EEmpirical Ventures
FFaber
MMacmillan VenturesPPioneer Group
PProven Connect
Companies like Neobe Therapeutics
LLabGenius$44M Series B+ · May 2024
AAI Proteins$41.5M Series A · Nov 2025
TThird Arc Bio$52M Series A · Feb 2026
TT-Knife$110M Series B+ · Aug 2021
AAikiumSeed · Mar 2026
VVilyaSeries A · Jun 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/neobe-therapeutics (get a free API key).